Abnormal Placenta Plant Disease Early Diagnosis and Individualized Treatment Research

Scarred Uterus Clinical Trial

Official title:

Abnormal Placenta Plant Disease Early Diagnosis and Individualized Treatment Research

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT02946749
• Other study ID #: Yinghao
• Status: Not yet recruiting
• Phase: N/A
• First received: October 22, 2016
• Last updated: July 30, 2017
• Start date: December 2016
• Est. completion date: December 2018

Study information

• Verified date: July 2017
• Source: Shanghai First Maternity and Infant Hospital
• Contact: Hao Ying, PHD
• Phone: 13371985049
• Email: stephenying2011[@]126.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

As the "two-child" policy implementation, caesarean women's clinical pregnancy is a huge problem again, Especially the placenta planting abnormal disease is a serious threat to the maternal health and life. Through this research, the investigators can obtain relevant epidemiological data and provide objective data for the department of public health policy; Predicting an placenta abnormal planting early diagnosis model was constructed, it will fill the blank in this field, and high-risk groups in the early stages of pregnancy will be taken proper disposal, the related complications will be reduced to ensure the safety of maternal.

Description:

This study focus on four hands: (1) to investigate different types of gestational sac implantation for pregnancy in caesarean women of childbearing age;(2) to explore the relationship between abnormal placenta planting disease in middle-late pregnancy and the different types of scar pregnancy (3) to explore the the value of ultrasound and serological markers for early diagnosis of placenta planting disease from scar pregnancy; (4) to compare the end and the influence of health economy of different termination method on scar pregnancy.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 3000
• Est. completion date: December 2018
• Est. primary completion date: December 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• Single pregnancies with once cesarean section history

• see a doctor before gestational 8 weeks in our study center

• will continue to pregnancy, high patient compliance

Exclusion Criteria:

• twins or multiple pregnancies

• hysteromyoma or adenomyoma stripping history

• history of intrauterine adhesions

Related Conditions & MeSH terms

• Scarred Uterus

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Shanghai First Maternity and Infant Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Placenta implanted		up to 37 gestational weeks
Secondary	Placenta previa		up to 37 gestational weeks